X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (6786) 6786
Book Review (1791) 1791
Publication (719) 719
Newsletter (119) 119
Newspaper Article (104) 104
Book Chapter (61) 61
Web Resource (29) 29
Book / eBook (28) 28
Conference Proceeding (24) 24
Dissertation (8) 8
Magazine Article (7) 7
Trade Publication Article (7) 7
Data Set (2) 2
Paper (1) 1
Reference (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (5965) 5965
multiple sclerosis (5341) 5341
humans (4919) 4919
female (3169) 3169
neurosciences (2818) 2818
male (2716) 2716
adult (2400) 2400
animals (2250) 2250
middle aged (1971) 1971
immunology (1763) 1763
clinical neurology (1730) 1730
experimental autoimmune encephalomyelitis (1517) 1517
multiple-sclerosis (1503) 1503
neurology (1368) 1368
central-nervous-system (1205) 1205
mice (1105) 1105
multiple sclerosis - metabolism (1025) 1025
inflammation (1015) 1015
multiple sclerosis - pathology (949) 949
multiple sclerosis - immunology (916) 916
experimental allergic encephalomyelitis (874) 874
research (858) 858
disease (825) 825
analysis (795) 795
multiple sclerosis - drug therapy (787) 787
magnetic resonance imaging (689) 689
brain (645) 645
expression (635) 635
young adult (602) 602
cytokines (591) 591
disease models, animal (586) 586
care and treatment (568) 568
t cells (568) 568
autoimmunity (559) 559
aged (553) 553
demyelination (547) 547
health aspects (544) 544
mice, inbred c57bl (542) 542
t-cells (538) 538
brain - pathology (531) 531
multiple sclerosis - physiopathology (530) 530
development and progression (526) 526
lymphocytes (513) 513
pharmacology & pharmacy (513) 513
cerebrospinal-fluid (501) 501
article (493) 493
cell biology (491) 491
multiple sclerosis - genetics (489) 489
autoimmune diseases (481) 481
biochemistry & molecular biology (479) 479
disease progression (479) 479
encephalomyelitis, autoimmune, experimental - immunology (477) 477
cells, cultured (475) 475
physiological aspects (465) 465
central nervous system (462) 462
case-control studies (451) 451
adolescent (449) 449
gene expression (448) 448
encephalomyelitis (446) 446
medicine (446) 446
nervous system (445) 445
allergy and immunology (423) 423
research article (423) 423
pathogenesis (422) 422
pathology (413) 413
multiple sclerosis, relapsing-remitting - drug therapy (410) 410
risk factors (405) 405
encephalomyelitis, autoimmune, experimental - pathology (401) 401
proteins (398) 398
multiple sclerosis - blood (397) 397
cytokines - metabolism (395) 395
disability (394) 394
medicine & public health (391) 391
lesions (390) 390
brain - metabolism (386) 386
interferon (379) 379
neurodegeneration (375) 375
sclerosis (374) 374
medical research (371) 371
abridged index medicus (367) 367
multiple sclerosis, relapsing-remitting - immunology (366) 366
activation (365) 365
rats (364) 364
multidisciplinary sciences (358) 358
review (357) 357
encephalomyelitis, autoimmune, experimental - metabolism (348) 348
patients (348) 348
double-blind (340) 340
cells (338) 338
genetic aspects (338) 338
biomedicine (334) 334
biomarkers (330) 330
multiple sclerosis - diagnosis (328) 328
multiple sclerosis, relapsing-remitting - metabolism (326) 326
rodents (322) 322
time factors (320) 320
t-lymphocytes - immunology (310) 310
interferon-beta - therapeutic use (309) 309
oxidative stress (309) 309
dendritic cells (308) 308
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (7073) 7073
Spanish (11) 11
Russian (10) 10
Turkish (5) 5
German (4) 4
Chinese (2) 2
French (2) 2
Hungarian (1) 1
Italian (1) 1
Polish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal of Trace Elements in Medicine and Biology, ISSN 0946-672X, 09/2019, Volume 55, pp. 39 - 43
Overproduction of reactive oxygen species (ROS) and impaired iron metabolism are considered to be possible factors in the pathogenesis of Multiple sclerosis... 
Multiple sclerosis | Iron | NADPH oxidase | Ferritin | Oxidases | Phosphates | Niacinamide | Medical research | C-reactive protein | Physiological aspects | Medicine, Experimental | Blood cell count | Protein binding | Index Medicus
Journal Article
FRONTIERS IN NEUROSCIENCE, ISSN 1662-453X, 02/2019, Volume 13, pp. 86 - 86
Journal Article
JOURNAL OF NEUROLOGY, ISSN 0340-5354, 11/2018, Volume 265, Issue 11, pp. 2614 - 2624
Background/objectives Fluoxetine and prucalopride might change phosphocreatine (PCr) levels via the cAMP-PKA pathway, an interesting target in the... 
CONTROLLED-TRIAL | Multiple sclerosis | WHITE-MATTER | Fluoxetine | TRANSCRIPTION | IMMUNOPATHOLOGY | Prucalopride | Phosphocreatine | ASTROCYTES | CLINICAL NEUROLOGY | Magnetic resonance spectroscopy | HIPPOCAMPUS | CREATINE-KINASE GENE | MAGNETIC-RESONANCE-SPECTROSCOPY | RECEPTORS
Journal Article
Journal of Neurology, ISSN 0340-5354, 11/2018, Volume 265, Issue 11, p. 2614
To access, purchase, authenticate, or subscribe to the full-text of this article, please visit this link: http://dx.doi.org/10.1007/s00415-018-9039-9... 
Complications and side effects | Multiple sclerosis | Usage | Fluoxetine | Nuclear magnetic resonance spectroscopy | Dosage and administration | Genetic aspects | Diagnosis | Research | Drug therapy
Journal Article
Acta Neurologica Scandinavica, ISSN 0001-6314, 12/2018, Volume 138, Issue 6, pp. 466 - 474
Journal Article
European Radiology, ISSN 0938-7994, 3/2018, Volume 28, Issue 3, pp. 1140 - 1148
To investigate if brain gamma-aminobutyric acid (GABA) levels in patients with relapsing-remitting multiple sclerosis (RRMS) are abnormal compared with healthy... 
MEGA-PRESS | Multiple sclerosis | 1 H-MRS | Medicine & Public Health | Diagnostic Radiology | GABA | Internal Medicine | Interventional Radiology | Imaging / Radiology | Ultrasound | Neuroradiology | Cognitive impairment | H-MRS | ATTENTION | EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS | PARVALBUMIN | MAGNETIC-RESONANCE-SPECTROSCOPY | INDIVIDUAL-DIFFERENCES | CINGULATE CORTEX | DISABILITY | MOTOR CORTEX | GAMMA-AMINOBUTYRIC-ACID | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | INTERNEURONS | H-1-MRS | Severity of Illness Index | Magnetic Resonance Spectroscopy - methods | gamma-Aminobutyric Acid - metabolism | Cognitive Dysfunction - metabolism | Humans | Middle Aged | Male | Cognitive Dysfunction - etiology | Temporal Lobe - metabolism | Case-Control Studies | Gyrus Cinguli - metabolism | Brain - metabolism | Neuropsychological Tests | Magnetic Resonance Imaging | Multiple Sclerosis, Relapsing-Remitting - psychology | Prefrontal Cortex - metabolism | Adult | Female | Multiple Sclerosis, Relapsing-Remitting - metabolism | Nuclear magnetic resonance spectroscopy | Care and treatment | Relapse | Diseases | Brain | Cortex (prefrontal) | Spectroscopy | Cortex (cingulate) | Pathogenesis | Abnormalities | Magnetic resonance | Cognitive ability | Impairment | Patients | Magnetic resonance spectroscopy | γ-Aminobutyric acid | Spectrum analysis | Interferon | Hippocampus | Neurotransmission | Index Medicus | 1H-MRS
Journal Article
Journal of Neuroinflammation, ISSN 1742-2094, 09/2012, Volume 9, Issue 1, pp. 215 - 215
Journal Article
American Journal of Clinical Nutrition, ISSN 0002-9165, 03/2015, Volume 101, Issue 3, pp. 487 - 495
Background: Muscle weakness and fatigue are common symptoms in multiple sclerosis (MS). Green tea catechins such as (-)epigallocatechin-3-gallate (EGCG) are... 
epigallocatechin-3-gallate | calorimetry | microdialysis | sex difference | multiple sclerosis | energy metabolism | MENSTRUAL-CYCLE | CAFFEINE | EXERCISE | GREEN TEA EXTRACT | CATECHOL-O-METHYLTRANSFERASE | FAT OXIDATION | NUTRITION & DIETETICS | ENERGY-EXPENDITURE | INHIBITION | EXPRESSION | FOOD | Neuroprotective Agents - therapeutic use | Carbohydrate Metabolism - drug effects | Humans | Immunosuppressive Agents - therapeutic use | Middle Aged | Glatiramer Acetate | Male | Muscle, Skeletal - metabolism | Motor Activity | Muscle, Skeletal - drug effects | Postprandial Period | Adult | Catechin - therapeutic use | Female | Dietary Supplements - adverse effects | Neuroprotective Agents - adverse effects | Catechin - adverse effects | Multiple Sclerosis, Relapsing-Remitting - metabolism | Severity of Illness Index | Double-Blind Method | Multiple Sclerosis, Relapsing-Remitting - drug therapy | Multiple Sclerosis, Relapsing-Remitting - physiopathology | Sex Characteristics | Combined Modality Therapy - adverse effects | Cross-Over Studies | Subcutaneous Fat, Abdominal - drug effects | Lipid Metabolism - drug effects | Immunosuppressive Agents - adverse effects | Multiple Sclerosis, Relapsing-Remitting - diet therapy | Catechin - analogs & derivatives | Subcutaneous Fat, Abdominal - metabolism | Energy Metabolism - drug effects | Peptides - adverse effects | Peptides - therapeutic use | Catechin | Multiple sclerosis | Clinical trials | Physiological aspects | Muscles | Glucose | Green tea | Dextrose | Care and treatment | Energy metabolism | Bioenergetics | Health aspects | Tea | Oxidation | Exercise | Metabolism | Index Medicus | Abridged Index Medicus
Journal Article
Metabolism, ISSN 0026-0495, 12/2017, Volume 77, pp. 39 - 46
Metabolic reprogramming is shaped to support specific cell functions since cellular metabolism controls the final outcome of immune response. Multiple... 
Adipocytokines | IFN beta-1a | Multiple sclerosis | Metabolism | EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS | ACTIVATION | RECEPTOR | OSTEOPROTEGERIN | INTERFERON-BETA | CEREBROSPINAL-FLUID | INFLAMMATION | ENDOCRINOLOGY & METABOLISM | GLATIRAMER ACETATE | LIGAND | Interferon beta-1a - therapeutic use | Multiple Sclerosis, Relapsing-Remitting - immunology | Lymphocyte Activation | Humans | Middle Aged | Oxidative Phosphorylation | Glucose Transporter Type 1 - metabolism | Male | Mitochondria - metabolism | Glycolysis - drug effects | Case-Control Studies | Young Adult | T-Lymphocytes - metabolism | Glucose Transporter Type 1 - drug effects | Adult | Female | T-Lymphocytes - pathology | Multiple Sclerosis, Relapsing-Remitting - metabolism | Glucose metabolism | Enzymes | Relapse | Physiological aspects | Interferon | Biological response modifiers | T cells | Diseases | Index Medicus | OCR, oxygen consumption rate | Th, T helper | E2, exone2 | MPO, myeloperoxidase | CIA, collagen-induced arthritis | DLAT, dihydrolipoamide S-acetyltransferase | BMI, body mass index | sICAM-1, soluble ICAM-1 | Tconv, conventional T cells | MCP-1, monocyte chemoattractant protein-1 | PBMCs, peripheral blood mononuclear cells | IFN, interferon | Treg, regulatory T cells | OPG, osteoprotegerin | RANKL, receptor activator of nuclear factor kappaB ligand | T1D, type 1 diabetes | sCD40L, soluble CD40 ligand | RR, relapsing remitting | sTNF-R, soluble tumor necrosis factor receptor | MS, multiple sclerosis | CNS, central nervous system | iTreg, inducible regulatory T cells | ECAR, extracellular acidification rate | sLeptinR, soluble leptin receptor | DLST, dihydrolipoamide succinyltransferase | TCR, T cell receptor | EAE, experimental autoimmune encephalomyelitis
Journal Article